{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:07Z","timestamp":1780750747205,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_15","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:00:29Z","timestamp":1753707629000},"page":"231-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Detection by RT-PCR and ELISA"],"prefix":"10.1007","author":[{"given":"Dyanna","family":"Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.pathol.2.010506.091936","volume":"2","author":"EM McNally","year":"2007","unstructured":"McNally EM, Pytel P (2007) Muscle diseases: the muscular dystrophies. Annu Rev Pathol Mech Dis 2:87\u2013109. https:\/\/doi.org\/10.1146\/annurev.pathol.2.010506.091936","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ncl.2014.05.002","volume":"32","author":"KM Flanigan","year":"2014","unstructured":"Flanigan KM (2014) Duchenne and Becker muscular dystrophies. Neurol Clin 32:671\u2013688. https:\/\/doi.org\/10.1016\/j.ncl.2014.05.002","journal-title":"Neurol Clin"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-4-431-55678-7","volume-title":"Translational research in muscular dystrophy","author":"JJA Lee","year":"2016","unstructured":"Lee JJA, Yokota T (2016) Translational research in nucleic acid therapies for muscular dystrophies. In: Translational research in muscular dystrophy, pp 87\u2013102. https:\/\/doi.org\/10.1007\/978-4-431-55678-7"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrd3625","volume":"11","author":"R Kole","year":"2012","unstructured":"Kole R, Krainer AR, Altman S (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11:125\u2013140. https:\/\/doi.org\/10.1038\/nrd3625","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/mt.2010.186","volume":"18","author":"Y Aoki","year":"2010","unstructured":"Aoki Y, Nakamura A, Yokota T et al (2010) In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol Ther 18:1995\u20132005. https:\/\/doi.org\/10.1038\/mt.2010.186","journal-title":"Mol Ther"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.21627","volume":"65","author":"T Yokota","year":"2009","unstructured":"Yokota T, Lu QL, Partridge T et al (2009) Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs. Ann Neurol 65:667\u2013676. https:\/\/doi.org\/10.1002\/ana.21627","journal-title":"Ann Neurol"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC et al (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci USA 102:198\u2013203. https:\/\/doi.org\/10.1073\/pnas.0406700102","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/JND-170233","volume":"4","author":"N Wein","year":"2017","unstructured":"Wein N, Vulin A, Findlay A et al (2017) Efficient skipping of single exon duplications in DMD patient-derived cell lines using an antisense oligonucleotide approach. J Neuromuscul Dis 4:199\u2013207","journal-title":"J Neuromuscul Dis"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DDDT.S97635","volume":"11","author":"KRQ Lim","year":"2017","unstructured":"Lim KRQ, Maruyama R, Yokota T (2017) Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther 11:533\u2013545. https:\/\/doi.org\/10.2147\/DDDT.S97635","journal-title":"Drug Des Devel Ther"},{"key":"15_CR10","doi-asserted-by":"publisher","unstructured":"Nguyen Q, Yokota T (2017) Immortalized muscle cell model to test the exon skipping efficacy for duchenne muscular dystrophy. J Pers Med 7. https:\/\/doi.org\/10.3390\/jpm7040013","DOI":"10.3390\/jpm7040013"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S et al (2015) The TREAT-NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations. Hum Mutat 36:395\u2013402. https:\/\/doi.org\/10.1002\/humu.22758","journal-title":"Hum Mutat"},{"key":"15_CR12","first-page":"2471","volume":"8","author":"Y Shimizu-motohashi","year":"2016","unstructured":"Shimizu-motohashi Y, Miyatake S, Komaki H et al (2016) Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials. Am J Transl Res 8:2471\u20132489","journal-title":"Am J Transl Res"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.1073\/pnas.0805676105","volume":"105","author":"B Wu","year":"2008","unstructured":"Wu B, Moulton HM, Iversen PL et al (2008) Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc Natl Acad Sci 105:14814\u201314819. https:\/\/doi.org\/10.1073\/pnas.0805676105","journal-title":"Proc Natl Acad Sci"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbrc.2004.12.191","volume":"328","author":"H Kudoh","year":"2005","unstructured":"Kudoh H, Ikeda H, Kakitani M et al (2005) A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system. Biochem Biophys Res Commun 328:507\u2013516. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.191","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/j.ymthe.2017.07.014","volume":"25","author":"Y Echigoya","year":"2017","unstructured":"Echigoya Y, Lim KRQ, Trieu N et al (2017) Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy. Mol Ther 25:2561\u20132572. https:\/\/doi.org\/10.1016\/j.ymthe.2017.07.014","journal-title":"Mol Ther"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/nat.2014.0528","volume":"25","author":"U Burki","year":"2015","unstructured":"Burki U, Keane J, Blain A et al (2015) Development and application of an ultrasensitive hybridization-based ELISA method for the determination of peptide-conjugated Phosphorodiamidate Morpholino oligonucleotides. Nucleic Acid Ther 25:275\u2013284. https:\/\/doi.org\/10.1089\/nat.2014.0528","journal-title":"Nucleic Acid Ther"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1101\/pdb.prot080887","volume":"2014","author":"DC Rio","year":"2014","unstructured":"Rio DC (2014) Reverse transcription??? Polymerase chain reaction. Cold Spring Harb Protoc 2014:1207\u20131216. https:\/\/doi.org\/10.1101\/pdb.prot080887","journal-title":"Cold Spring Harb Protoc"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1073\/pnas.1613203114","volume":"114","author":"Y Echigoya","year":"2017","unstructured":"Echigoya Y, Nakamura A, Nagata T et al (2017) Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy. Proc Natl Acad Sci 114:4213\u20134218. https:\/\/doi.org\/10.1073\/pnas.1613203114","journal-title":"Proc Natl Acad Sci"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:04:26Z","timestamp":1780747466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}